{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:08:46Z","timestamp":1788232126729,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.radonc.2014.11.037","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T23:46:49Z","timestamp":1419896809000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?"],"prefix":"10.1016","volume":"114","author":[{"given":"Jannet C.","family":"Beukema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Luijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Widder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina T.","family":"Muijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2014.11.037_b0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2014.11.037_b0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00535-006-1771-8","article-title":"Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma","volume":"41","author":"Kumekawa","year":"2006","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.radonc.2014.11.037_b0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijrobp.2008.10.075","article-title":"Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma","volume":"75","author":"Morota","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.11.037_b0020","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","article-title":"Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus","volume":"21","author":"Ishikura","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0360-3016(97)00584-1","article-title":"Fraction size and dose parameters related to the incidence of pericardial effusions","volume":"40","author":"Martel","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.11.037_b0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","article-title":"Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy","volume":"70","author":"Wei","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.11.037_b0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2010.03.046","article-title":"Dose\u2013volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients","volume":"80","author":"Shirai","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.11.037_b0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/clon.2003.0218","article-title":"The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers","volume":"15","author":"Mukherjee","year":"2003","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1442-2050.2005.00523.x","article-title":"Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose\u2013volume histogram parameters to multiple gated acquisition scan changes","volume":"18","author":"Tripp","year":"2005","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.radonc.2014.11.037_b0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10554-009-9440-7","article-title":"The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy","volume":"25","author":"Gayed","year":"2009","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.radonc.2014.11.037_b0055","first-page":"1756","article-title":"The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer","volume":"47","author":"Gayed","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2014.11.037_b0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.radonc.2012.04.016","article-title":"Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer","volume":"104","author":"Konski","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0065","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.ijrobp.2011.12.018","article-title":"Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: magnetic resonance evaluation","volume":"83","author":"Hatakenaka","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.11.037_b0070","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijrobp.2006.06.007","article-title":"The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage","volume":"66","author":"Jingu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.11.037_b0075","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","article-title":"Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis","volume":"8","author":"Gebski","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0085","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9610(03)00066-7","article-title":"A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer","volume":"185","author":"Urschel","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.radonc.2014.11.037_b0090","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"Van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2014.11.037_b0095","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1200\/jco.2010.28.15_suppl.4005","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for localised esophageal cancer: analysis of a randomised controlled phase III trial FFCD 9901","volume":"28","author":"Mariette","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0100","article-title":"Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients","volume":"21","author":"Bosch","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(98)06341-7","article-title":"Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2014.11.037_b0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.icrp.2012.06.031","article-title":"Mechanisms and dose\u2013response relationships for radiation-induced cardiovascular disease","volume":"41","author":"Stewart","year":"2011","journal-title":"Ann ICRP"},{"key":"10.1016\/j.radonc.2014.11.037_b0115","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer","volume":"349","author":"Enzinger","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2014.11.037_b0120","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors","volume":"39","author":"Polk","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2014.11.037_b0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2362.2005.01460.x","article-title":"Left ventricular and cardiac autonomic function in survivors of testicular cancer","volume":"35","author":"Nuver","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.radonc.2014.11.037_b0130","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/sj.bjc.6605095","article-title":"Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer","volume":"100","author":"Altena","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2014.11.037_b0135","doi-asserted-by":"crossref","first-page":"824135","DOI":"10.1155\/2013\/824135","article-title":"Similarities and differences between the pathogenesis and pathophysiology of diastolic and systolic heart failure","volume":"2013","author":"Komamura","year":"2013","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.radonc.2014.11.037_b0140","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2013.01.017","article-title":"Ionising radiation induces persistent alterations in the cardiac mitochondrial function of C57BL\/6 mice 40weeks after local heart exposure","volume":"106","author":"Barjaktarovic","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0145","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.radonc.2012.08.002","article-title":"Local heart irradiation of ApoE(\u2212\/\u2212) mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis","volume":"105","author":"Gabriels","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2011.10.011","article-title":"Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature","volume":"103","author":"Seemann","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0155","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2011.06.016","article-title":"Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden","volume":"100","author":"McGale","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2013.06.025","article-title":"Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: a multi-centre study from Denmark and the UK","volume":"108","author":"Lorenzen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.11.037_b0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814014005428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814014005428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T22:30:03Z","timestamp":1566167403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814014005428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0167814014005428"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2014.11.037","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2014.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}